Drug Manufacturers - Specialty & Generic · Healthcare
CFO
2025-07-07–present
Equibles does not estimate personal net worth.
Get an email with a short summary when Elanco Animal Health Inc publishes a filing, an earnings call transcript or a press release.
Get ELAN alertsRobert (Bob) VanHimbergen is recorded as CFO at Elanco Animal Health Inc (ELAN) since July 7, 2025. Elanco Animal Health Inc reported in an 8-K filed May 28, 2025 that Robert (Bob) VanHimbergen was appointed Executive Vice President and Chief Financial Officer, effective July 7, 2025. Robert (Bob) VanHimbergen has spoken on 2 earnings calls and 2 other investor events across 1 company, most recently for Elanco Animal Health Inc on September 15, 2026. Elanco Animal Health Inc is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Elanco Animal Health Inc includes Jeffrey N. Simmons (CEO and Board Member), Jeffrey Simmons (CEO and Board Member), Todd S. Young (CFO) and 7 others.
“the Company announced the appointment of Robert (Bob) VanHimbergen as Executive Vice President and Chief Financial Officer, effective July 7, 2025.”
“So on pricing, things have played out exactly as we had anticipated. First half of the year, we saw pricing of about 2%, and that's really across farm and pet. It's across international and U.S., so it's pretty broad-based.”
“My comments today will focus on our adjusted results for the second quarter. Please refer to today's earnings press release for the details of our reported year-over-year results.”
“That was right in line with our expectations. And we've been clear that we expect price to be an accelerator in 2026 versus 2025, and why we have conviction around that, we did take the highest pricing out to the vet clinics.”
“Starting on Slide 11, we delivered $1.14 billion of revenue in the fourth quarter, representing an increase of 12% on a reported basis. Organic constant currency growth was 9%, primarily driven by an increase in volume with price contributing.”
2025-07-07–present
Drug Manufacturers - Specialty & Generic · Healthcare
CFO
2025-07-07–present